Exfoliation Syndrome: Development of a cell culture model of fibril formation
Exfoliation Syndrome: Development of a cell culture model of fibril formation
批准号:
7659835
负责人:
JORGE A GHISO
金额:
$21.19万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2011-03-31
关键词:
AccountingAgeAngle-Closure GlaucomaAnimal Disease ModelsAnimal ModelAnteriorAqueous HumorBasement membraneBathingBinding ProteinsBiochemicalCandidate Disease GeneCell Adhesion MoleculesCell Culture TechniquesCellsCharacteristicsChondroitin SulfatesCiliary BodyComplementComplex MixturesCoupledCyanogen BromideDataDepositionDetectionDevelopmentDiseaseDisease MarkerElastinElementsEpithelialEpithelial CellsExfoliation SyndromeExtracellular MatrixExtracellular Matrix ProteinsFBN1FiberFibroblastsFibronectinsFormic AcidsFutureGene ExpressionGenerationsGlaucomaGlycoproteinsImmunoelectron MicroscopyImmunohistochemistryIn VitroIndividualInterventionIrisKineticsLesionLiquid substanceMass Spectrum AnalysisMetalloproteasesMethodologyModelingMolecularMolecular ChaperonesNID geneNidogenOperative Surgical ProceduresPathologicPathway interactionsPatientsPigmentsPopulationProductionProteinsProteoglycanProteomicsProtocols documentationRecruitment ActivityResearchSerum Amyloid P-ComponentSpecimenStructureStudy SectionSubstantia PropriaSurfaceSyndromeSystemTherapeutic InterventionTimeTissuesVitronectinage relatedaqueousbasecell typeexperienceextracellulargenetic manipulationin vivoinhibitor/antagonistlaminin-8lensnovelprogesterone 11-hemisuccinate-(2-iodohistamine)prospectivepublic health relevanceresearch studysulfated glycoprotein 2
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Exfoliation syndrome (XFS), an age-related disorder which constitutes the most common identifiable cause of open-angle and angle-closure glaucoma, is characterized by the accumulation of an abnormal fibrillar material (XFM) in many intraocular tissues, particularly those structures that line the aqueous-bathed surfaces of the anterior segment. Deposits of XFM are composed of a complex mixture of extracellular matrix glycoproteins and proteoglycans assembled in a supramolecular fibrillar structure. Due to the highly diverse biochemical composition it is still not clear which are the primary elements involved in the formation of XF fibers and whether some of the deposited components or their immediate precursors are recruited to the lesions from the surrounding fluids (e.g. aqueous). Thus, despite all available information, there is still no data pointing out to specific candidate genes to support the generation of animal models. An understudied alternative approach is the development of a culture model that produces XF-like fibers in vitro, a potentially valuable paradigm that would allow the search for the pathogenetic pathway(s) leading to disease, conduct time-course kinetics of fibril assembly, supply fibrils for detailed biochemical analysis and be eventually amenable for pharmacologic interventions. In this sense, and as extensively illustrated in the Preliminary Studies section, we have obtained encouraging data from culturing Tenon's capsule fibroblasts from XFS patients in tri-dimensional systems, documenting the production of XF fibrils ultrastructurally similar, if not identical, to those observed in vivo. Based on our results we hypothesize that the use of selected XFS ocular cells in culture will provide a much needed model to study XF fibril assembly. To this end, we will take advantage of cutting-edge proteomic approaches, the availability of surgical specimens to establish a diversity of primary cultures from individuals with and without XFS, the accessibility to aqueous humors from the same cases, the newly developed Tenon's fibroblasts tri-dimensional cultures as well as previous technical experience acquired by the research group in culturing iris pigmented epithelial (IPE) cells to: (a) conduct proteomic analysis of XF-like fibrils produced in vitro by Tenon's fibroblasts from XFS cases; (b) verify whether cells obtained form IPE of XFS patients, cultured under various conditions, produce XF-like fibrils with the same EM characteristics and biochemical composition than Tenon's fibroblasts and/or XF fibrils produced in vivo; (c) identify common proteomic differences in the composition of the various culture supernatants of XFS vs. non-XFS controls and validate, through the parallel analysis of aqueous fluids from the same XFS and non- XFS controls, whether the observed differences might serve as prospective signature markers of the disease. The data generated by the proposed experiments will constitute the basis of a future R01 application. PUBLIC HEALTH RELEVANCE: Exfoliation (XF) syndrome is an age-related disorder which constitutes the most common identifiable cause of glaucoma worldwide. The extreme diversity of the molecules composing the XF lesions has so far precluded the creation of a much needed animal model of the disease. We propose to biochemically and ultrastructurally characterize a promising cell culture paradigm that produces XF-like fibers in vitro, which may prove to be a useful alternative approach to study the molecular basis of the disease and explore novel pharmacologic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Insights into the Brain Clearance Mechanisms of Oligomeric Beta-Amyloid Species
-
批准号:8970773
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2015
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:8668390
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2013
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:8240456
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:7919047
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:8452683
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:7653286
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:8414469
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Exfoliation Syndrome: Development of a cell culture model of fibril formation
-
批准号:7796658
-
项目类别:
-
资助金额:$25.17万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:7800308
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
Cerebral Amyloidosis and Dementia
-
批准号:8049051
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2009
-
负责人:JORGE A GHISO
-
依托单位:
APOLIPOPROTEINS AND A-BETA CATABOLISM
-
批准号:7056888
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2005
-
负责人:JORGE A GHISO
-
依托单位:
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL
-
批准号:6330601
-
项目类别:
-
资助金额:$25.73万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL
-
批准号:6046223
-
项目类别:
-
资助金额:$24.02万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL
-
批准号:6685966
-
项目类别:
-
资助金额:$28.23万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL
-
批准号:6477145
-
项目类别:
-
资助金额:$26.54万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL
-
批准号:6625460
-
项目类别:
-
资助金额:$27.37万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
PROTEIN SEQUENCER SYSTEM
-
批准号:2804036
-
项目类别:
-
资助金额:$14.2万
-
财政年份:1999
-
负责人:JORGE A GHISO
-
依托单位:
ALTERNATIVE PROCESSING AND CHARACTERISTICS OF AMYLOID PRECURSOR PROTEIN
-
批准号:6098462
-
项目类别:
-
资助金额:$13.14万
-
财政年份:1998
-
负责人:JORGE A GHISO
-
依托单位:
ALTERNATIVE PROCESSING AND CHARACTERISTICS OF AMYLOID PRECURSOR PROTEIN
-
批准号:6234428
-
项目类别:
-
资助金额:$12.74万
-
财政年份:1997
-
负责人:JORGE A GHISO
-
依托单位:
ALTERNATIVE PROCESSING AND CHARACTERISTICS OF AMYLOID PRECURSOR PROTEIN
-
批准号:5204868
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JORGE A GHISO
-
依托单位:--
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: